We are live on
!
Find out more
Capital Fund Management (CFM) Portfolio holdings
AUM
$22.1B
1-Year Est. Return
20.49%
This Fund
S&P 500
This Quarter
Est. Return
+1.25%
1 Year Est. Return
+20.49%
3 Year Est. Return
+61.01%
5 Year Est. Return
+50.59%
10 Year Est. Return
+196.1%
AUM
$11B
AUM Growth
-$189M
(-1.7%)
Cap. Flow
-$328M
Cap. Flow
% of AUM
-2.98%
Top 10 Holdings %
Top 10 Hldgs %
8.61%
Holding
2,081
New
461
Increased
504
Reduced
578
Closed
524
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$117M |
| 2 |
JPMorgan Chase
JPM
|
+$59.9M |
| 3 |
Procter & Gamble
PG
|
+$59.1M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$58.2M |
| 5 |
Intuit
INTU
|
+$46.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$78.3M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$75.4M |
| 3 |
Amazon
AMZN
|
+$60.9M |
| 4 |
Alibaba
BABA
|
+$48.1M |
| 5 |
Starbucks
SBUX
|
+$40.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.02% |
| 2 | Consumer Discretionary | 6.48% |
| 3 | Financials | 5.72% |
| 4 | Healthcare | 5.62% |
| 5 | Industrials | 4.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1201
CALL
Boston Beer
SAM
$1.91B
| $529K | ﹤0.01% |
1,400
-9,300
| -87% | -$2.94M |
|
1202
Heartland Express
HTLD
$948M
| $528K | ﹤0.01% |
+29,200
| New | +$558K |
|
1203
PUT
Entergy
ETR
$50.2B
| $525K | ﹤0.01% |
+10,200
| New | +$497K |
|
1204
PUT
Ligand Pharmaceuticals
LGND
$5.76B
| $525K | ﹤0.01% |
7,374
-962
| -12% | -$70.9K |
|
1205
Mercury Insurance
MCY
$5.93B
| $525K | ﹤0.01% |
8,400
+3,200
| +62% | +$179K |
|
1206
Enanta Pharmaceuticals
ENTA
$366M
| $523K | ﹤0.01% |
+6,200
| New | +$558K |
|
1207
STMicroelectronics
STM
$46.7B
| $522K | ﹤0.01% |
29,619
-251,206
| -89% | -$4.25M |
|
|
BNFT
1208
DELISTED
Benefitfocus, Inc.
BNFT
| $521K | ﹤0.01% |
19,200
+12,900
| +205% | +$433K |
|
1209
CALL
Everest Group
EG
$14.5B
| $519K | ﹤0.01% |
+2,100
| New | +$504K |
|
1210
CALL
Macy's
M
$6.53B
| $519K | ﹤0.01% |
24,200
+7,800
| +48% | +$177K |
|
1211
CALL
Rio Tinto
RIO
$158B
| $517K | ﹤0.01% |
+8,300
| New | +$497K |
|
|
BHVN
1212
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $517K | ﹤0.01% |
+11,800
| New | +$665K |
|
1213
Equinix
EQIX
$101B
| $516K | ﹤0.01% |
+1,023
| New | +$491K |
|
1214
CALL
Macerich
MAC
$7.33B
| $516K | ﹤0.01% |
+15,400
| New | +$605K |
|
1215
Devon Energy
DVN
$52.1B
| $514K | ﹤0.01% |
+18,005
| New | +$535K |
|
|
1216
CALL
JPMorgan Chase
JPM
$935B
| $514K | ﹤0.01% |
4,600
-2,400
| -34% | -$265K |
|
1217
Arch Capital
ACGL
$34.3B
| $504K | ﹤0.01% |
+13,600
| New | +$464K |
|
1218
CALL
Sherwin-Williams
SHW
$82.7B
| $504K | ﹤0.01% |
3,300
-900
| -21% | -$134K |
|
|
RAVN
1219
DELISTED
Raven Industries Inc
RAVN
| $502K | ﹤0.01% |
14,000
-2,000
| -13% | -$73.3K |
|
|
SEE
1220
CALL
DELISTED
Sealed Air
SEE
| $501K | ﹤0.01% |
11,700
-8,700
| -43% | -$383K |
|
|
WLL
1221
PUT
DELISTED
Whiting Petroleum Corporation
WLL
| $499K | ﹤0.01% |
356
+213
| +149% | +$366K |
|
1222
CALL
CSX Corp
CSX
$93.4B
| $495K | ﹤0.01% |
+19,200
| New | +$495K |
|
1223
CALL
Ventas
VTR
$48B
| $492K | ﹤0.01% |
7,200
-77,900
| -92% | -$4.97M |
|
|
FISV
1224
Fiserv Inc
FISV
$28.8B
| $490K | ﹤0.01% |
+5,373
| New | +$471K |
|
1225
CALL
Broadcom
AVGO
$1.85T
| $489K | ﹤0.01% |
17,000
+8,000
| +89% | +$233K |
|
Similar funds
AM
BA
DSA
IC
FAM
CAM
Capital Fund Management (CFM)'s Q2 2019 Portfolio in Review
As of Q2 2019, Capital Fund Management (CFM) held 2,081 positions worth $11B, down 1.7% from $11.2B the previous quarter. Its ten largest holdings account for 8.6% of the portfolio.
Capital Fund Management (CFM)'s Q2 2019 filing shows 461 new, 504 increased, 578 reduced and 524 closed positions. Its largest new stake was Eli Lilly: 994,638 shares worth $110M. The largest sale was UnitedHealth, an estimated $78.3M.
By sector, the portfolio is most concentrated in Technology at 8% of assets, up from 5.3% a quarter earlier, followed by Consumer Discretionary and Financials.
- Capital Fund Management (CFM)'s largest Q2 2019 buy was Eli Lilly: 994,638 shares worth $110M.
- Capital Fund Management (CFM) added most to Alphabet (Google) Class A in Q2 2019, an estimated $58.2M increase.
- Capital Fund Management (CFM)'s biggest Q2 2019 reduction was Amazon, cutting an estimated $60.9M.
- Capital Fund Management (CFM) fully exited UnitedHealth in Q2 2019, selling an estimated $78.3M.
- Capital Fund Management (CFM)'s ten largest holdings make up 8.6% of its $11B portfolio in Q2 2019.
- Capital Fund Management (CFM) opened 461 new positions and closed 524 in Q2 2019.
- Capital Fund Management (CFM)'s portfolio value fell 1.7% quarter-over-quarter to $11B.
Based on Capital Fund Management (CFM)'s 13F filing for Q2 2019, filed 12 Aug 2019.